Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.584 USD | +4.03% | +12.00% | +8.54% |
05-09 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
Sales 2024 * | 42.83M 3.42B | Sales 2025 * | 69.73M 5.57B | Capitalization | 116M 9.3B |
---|---|---|---|---|---|
Net income 2024 * | -98M -7.82B | Net income 2025 * | -53M -4.23B | EV / Sales 2024 * | 3.67 x |
Net Debt 2024 * | 40.79M 3.26B | Net Debt 2025 * | 129M 10.31B | EV / Sales 2025 * | 3.52 x |
P/E ratio 2024 * |
-1.03
x | P/E ratio 2025 * |
-2.07
x | Employees | 405 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.28% |
Latest transcript on Sangamo Therapeutics, Inc.
1 day | +7.26% | ||
1 week | +1.01% | ||
Current month | +9.03% | ||
1 month | +3.31% | ||
3 months | -30.26% | ||
6 months | +88.96% | ||
Current year | +3.33% |
Managers | Title | Age | Since |
---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 61 | 31/05/16 |
Director of Finance/CFO | 46 | 28/02/19 | |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peg Horn
BRD | Director/Board Member | 61 | 14/12/22 |
James Meyers
BRD | Director/Board Member | 59 | 21/11/19 |
H. Parker
CHM | Chairman | 68 | 18/06/14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.66% | 2 M€ | -25.75% | ||
0.49% | 0 M€ | -4.28% |
Date | Price | Change | Volume |
---|---|---|---|
13/05/24 | 0.5897 | +5.04% | 1 312 923 |
10/05/24 | 0.5614 | +7.26% | 4,769,970 |
09/05/24 | 0.5234 | +4.18% | 2,280,030 |
08/05/24 | 0.5024 | -6.95% | 1,572,874 |
07/05/24 | 0.5399 | +2.55% | 1,660,592 |
Delayed Quote Nasdaq, May 10, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.33% | 116M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.09% | 22.25B | |
-13.14% | 22.09B | |
-8.26% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- SGMO Stock